Drug Profile
BL 1872
Latest Information Update: 03 Dec 2002
Price :
$50
*
At a glance
- Originator Bioglan Pharma [CEASED]
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 03 Dec 2002 Discontinued - Preclinical for Pain in United Kingdom (unspecified route)
- 18 Jun 2001 Preclinical development for Pain in United Kingdom (Unknown route)